EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
CHEBI:4551 - digoxin
| Formula | C41H64O14 |
| Net Charge | 0 |
| Average Mass | 780.949 |
| Monoisotopic Mass | 780.42961 |
| SMILES | [H][C@]12CC[C@]3([H])[C@]([H])(C[C@@H](O)[C@]4(C)[C@@H](C5=CC(=O)OC5)CC[C@@]43O)[C@@]1(C)CC[C@H](O[C@H]1C[C@H](O)[C@H](O[C@H]3C[C@H](O)[C@H](O[C@H]4C[C@H](O)[C@H](O)[C@@H](C)O4)[C@@H](C)O3)[C@@H](C)O1)C2 |
| InChI | InChI=1S/C41H64O14/c1-19-36(47)28(42)15-34(50-19)54-38-21(3)52-35(17-30(38)44)55-37-20(2)51-33(16-29(37)43)53-24-8-10-39(4)23(13-24)6-7-26-27(39)14-31(45)40(5)25(9-11-41(26,40)48)22-12-32(46)49-18-22/h12,19-21,23-31,33-38,42-45,47-48H,6-11,13-18H2,1-5H3/t19-,20-,21-,23-,24+,25-,26-,27+,28+,29+,30+,31-,33+,34+,35+,36-,37-,38-,39+,40+,41+/m1/s1 |
| InChIKey | LTMHDMANZUZIPE-PUGKRICDSA-N |
| Wikipedia |
|---|
| Roles Classification |
|---|
| Biological Roles: | epitope The biological role played by a material entity when bound by a receptor of the adaptive immune system. Specific site on an antigen to which an antibody binds. analgesic An agent capable of relieving pain without the loss of consciousness or without producing anaesthesia. In addition, analgesic is a role played by a compound which is exhibited by a capability to cause a reduction of pain symptoms. anti-obesity agent Any substance which is used to reduce or control weight. anti-HBV agent An antiviral agent that destroys or inhibits the replication of the hepatitis B virus. EC 3.6.3.9 (Na(+)/K(+)-transporting ATPase) inhibitor An EC 3.6.3.* (acid anhydride hydrolase catalysing transmembrane movement of substances) inhibitor that interferes with the action of Na+/K+-transporting ATPase (EC 3.6.3.9). anti-HIV agent An antiviral agent that destroys or inhibits the replication of the human immunodeficiency virus. antiviral agent A substance that destroys or inhibits replication of viruses. metabolite Any intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites. |
| Applications: | antiinfective agent A substance used in the prophylaxis or therapy of infectious diseases. cardiovascular drug A drug that affects the rate or intensity of cardiac contraction, blood vessel diameter or blood volume. analgesic An agent capable of relieving pain without the loss of consciousness or without producing anaesthesia. In addition, analgesic is a role played by a compound which is exhibited by a capability to cause a reduction of pain symptoms. antirheumatic drug A drug used to treat rheumatoid arthritis. anticonvulsant A drug used to prevent seizures or reduce their severity. anti-arrhythmia drug A drug used for the treatment or prevention of cardiac arrhythmias. Anti-arrhythmia drugs may affect the polarisation-repolarisation phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibres. antihypertensive agent Any drug used in the treatment of acute or chronic vascular hypertension regardless of pharmacological mechanism. antineoplastic agent A substance that inhibits or prevents the proliferation of neoplasms. cardiotonic drug A drug that has a strengthening effect on the heart or that can increase cardiac output. antidepressant Antidepressants are mood-stimulating drugs used primarily in the treatment of affective disorders and related conditions. anti-inflammatory agent Any compound that has anti-inflammatory effects. hypoglycemic agent A drug which lowers the blood glucose level. antiemetic A drug used to prevent nausea or vomiting. An antiemetic may act by a wide range of mechanisms: it might affect the medullary control centres (the vomiting centre and the chemoreceptive trigger zone) or affect the peripheral receptors. cardioprotective agent Any protective agent that is able to prevent damage to the heart. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| digoxin (CHEBI:4551) has role analgesic (CHEBI:35480) |
| digoxin (CHEBI:4551) has role anti-arrhythmia drug (CHEBI:38070) |
| digoxin (CHEBI:4551) has role anti-HBV agent (CHEBI:64951) |
| digoxin (CHEBI:4551) has role anti-HIV agent (CHEBI:64946) |
| digoxin (CHEBI:4551) has role anti-inflammatory agent (CHEBI:67079) |
| digoxin (CHEBI:4551) has role anti-obesity agent (CHEBI:74518) |
| digoxin (CHEBI:4551) has role anticonvulsant (CHEBI:35623) |
| digoxin (CHEBI:4551) has role antidepressant (CHEBI:35469) |
| digoxin (CHEBI:4551) has role antiemetic (CHEBI:50919) |
| digoxin (CHEBI:4551) has role antihypertensive agent (CHEBI:35674) |
| digoxin (CHEBI:4551) has role antiinfective agent (CHEBI:35441) |
| digoxin (CHEBI:4551) has role antineoplastic agent (CHEBI:35610) |
| digoxin (CHEBI:4551) has role antirheumatic drug (CHEBI:35842) |
| digoxin (CHEBI:4551) has role antiviral agent (CHEBI:22587) |
| digoxin (CHEBI:4551) has role cardiotonic drug (CHEBI:38147) |
| digoxin (CHEBI:4551) has role cardiovascular drug (CHEBI:35554) |
| digoxin (CHEBI:4551) has role EC 3.6.3.9 (Na+/K+-transporting ATPase) inhibitor (CHEBI:63510) |
| digoxin (CHEBI:4551) has role epitope (CHEBI:53000) |
| digoxin (CHEBI:4551) has role hypoglycemic agent (CHEBI:35526) |
| digoxin (CHEBI:4551) is a cardenolide glycoside (CHEBI:38092) |
| digoxin (CHEBI:4551) is a organic molecular entity (CHEBI:50860) |
| digoxin (CHEBI:4551) is a steroid saponin (CHEBI:61655) |
| digoxin (CHEBI:4551) is conjugate acid of digoxin(1−) (CHEBI:145795) |
| Incoming Relation(s) |
| 12-O-acetyldigoxin (CHEBI:71006) has functional parent digoxin (CHEBI:4551) |
| 20,22-dihydrodigoxin (CHEBI:71002) has functional parent digoxin (CHEBI:4551) |
| digoxin(1−) (CHEBI:145795) is conjugate base of digoxin (CHEBI:4551) |
| IUPAC Name |
|---|
| (3β,5β,12β)-3-{[2,6-dideoxy-β-D-ribo-hexopyranosyl-(1→4)-2,6-dideoxy-β-D-ribo-hexopyranosyl-(1→4)-2,6-dideoxy-β-D-ribo-hexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide |
| INNs | Source |
|---|---|
| digoxin | ChemIDplus |
| digoxina | WHO MedNet |
| Synonyms | Source |
|---|---|
| 12β-hydroxydigitoxin | ChemIDplus |
| Digoxinum | ChEMBL |
| Fargoxin | ChEMBL |
| Lanocardin | ChEMBL |
| Mapluxin | ChEMBL |
| Natigoxin | ChEMBL |
| Brand Names | Source |
|---|---|
| Digamex | ChEMBL |
| Lanoxin-125 | ChEMBL |
| Lanoxin pediatric | ChEMBL |
| Lanoxin-pg | ChEMBL |
| Citations |
|---|